July 13, 2018
Rose
Like clockwork, Pfizer has been raising prices every six months, flying under the radar because most pharma companies were doing the same. But then the company caught the attention of President Donald Trump, and everything changed. In other pharmaceutical news: Novartis ditches antibiotics research; a patient advocacy group highlights a New Jersey candidate's ties to high prices; and an experimental epilepsy drug moves forward toward approval.
from Kaiser Health News https://ift.tt/2L6CVeJ
July 13, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
First Edition: July 31, 2019- Trump Administration Moves To Make Health Care Costs More Transparent
- Lawmaker Targets Infinite Scroll, Other Techniques To Keep Users Mindlessly Engaged In Apps
- Hospital System That Was Suing The Low-Income Patients It Was Supposed To Help Announces Major Policy Change
- Medicaid Expansion Advocates See Voters As The Way To Break Through Political Gridlock In Red States
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment